Proposal for a Standardized Pathology Report of Gastroenteropancreatic Neuroendocrine Tumors: Prognostic Significance of Pathological Parameters
2
조회
0
다운로드
2
인용
0
참고문헌
초록
Background: There is confusion in the diagnosis and biological behaviors of gastroenteropancreatic neuroendocrine tumors (GEP-NETs), because of independently proposed nomenclatures and classifications. A standardized form of pathology report is required for the proper management of patients. Methods: We discussed the proper pathological evaluation of GEP-NET at the consensus conference of the subcommittee meeting for the Gastrointestinal Pathology Study Group of the Korean Society of Pathologists. We then verified the prognostic significance of pathological parameters from our previous nationwide collection of pathological data from 28 hospitals in Korea to determine the essential data set for a pathology report. Results: Histological classification, grading (mitosis and/or Ki-67 labeling index), T staging (extent, size), lymph node metastasis, and lymphovascular and perineural invasion were significant prognostic factors and essential for the pathology report of GEP-NET, while immunostaining such as synaptophysin and chromogranin may be optional. Furthermore, the staging system, either that of the 2010 American Joint Cancer Committee (AJCC) or the European Neuroendocrine Tumor Society (ENETS), should be specified, especially for pancreatic neuroendocrine neoplasms. Conclusions: A standardized pathology report is crucial for the proper management and prediction of prognosis of patients with GEP-NET.
Abstract
Background: There is confusion in the diagnosis and biological behaviors of gastroenteropancreatic neuroendocrine tumors (GEP-NETs), because of independently proposed nomenclatures and classifications. A standardized form of pathology report is required for the proper management of patients. Methods: We discussed the proper pathological evaluation of GEP-NET at the consensus conference of the subcommittee meeting for the Gastrointestinal Pathology Study Group of the Korean Society of Pathologists. We then verified the prognostic significance of pathological parameters from our previous nationwide collection of pathological data from 28 hospitals in Korea to determine the essential data set for a pathology report. Results: Histological classification, grading (mitosis and/or Ki-67 labeling index), T staging (extent, size), lymph node metastasis, and lymphovascular and perineural invasion were significant prognostic factors and essential for the pathology report of GEP-NET, while immunostaining such as synaptophysin and chromogranin may be optional. Furthermore, the staging system, either that of the 2010 American Joint Cancer Committee (AJCC) or the European Neuroendocrine Tumor Society (ENETS), should be specified, especially for pancreatic neuroendocrine neoplasms. Conclusions: A standardized pathology report is crucial for the proper management and prediction of prognosis of patients with GEP-NET.
참고문헌 (28)
- 조미연, "Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000-2009: Multicenter Study", Cancer Research and Treatment, 44(3), pp.157~165 (2012), 대한암학회
- Klöppel G, "The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification", Ann N Y Acad Sci, 1014, pp.13~27 (2004)
- Rindi G, "Neuroendocrine neoplasms of the gut and pancreas: new insights", Nat Rev Endocrinol, 8, pp.54~64 (2012)
- Williams ED, "Histological typing of endocrine tumours" (1980), World Health Organization
- Solcia E, "World Health Organization international histological classification of tumours: histological typing of endocrine tumors", pp.56~68 (2000), Springer
- Bosman FT, "WHO classification of tumours of the digestive system" (2010), IARC Press
- Klöppel G, "Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors", Virchows Arch, 451(Suppl 1), pp.9~27 (2007)
- Edge SB, "The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM", Ann Surg Oncol, 17, pp.1471~1474 (2010)
- Kloppel G, "Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms", Endocr Relat Cancer, 18(Suppl 1), pp.1~16 (2011)
- Remes SM, "Grading of neuroendocrine tumors with Ki-67 requires high-quality assessment practices", Am J Surg Pathol, 36, pp.1359~1363 (2012)
- Klimstra DS, "Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set", Am J Surg Pathol, 34, pp.300~313 (2010)
- Klöppel G, "ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification", Neuroendocrinology, 90, pp.162~166 (2009)
- Anthony LB, "The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectum", Pancreas, 39, pp.767~774 (2010)
- Boudreaux JP, "The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the jejunum, ileum, appendix, and cecum", Pancreas, 39, pp.753~766 (2010)
- Volante M, "The pathological diagnosis of neuroendocrine tumors: common questions and tentative answers", Virchows Arch, 458, pp.393~402 (2011)
- Washington MK, "Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the colon and rectum", Arch Pathol Lab Med, 134, pp.176~180 (2010)
- Washington MK, "Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the stomach", Arch Pathol Lab Med, 134, pp.187~191 (2010)
- Washington MK, "Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the small intestine and ampulla", Arch Pathol Lab Med, 134, pp.181~186 (2010)
- Washington MK, "Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the appendix", Arch Pathol Lab Med, 134, pp.171~175 (2010)
- Kulke MH, "NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas", Pancreas, 39, pp.735~752 (2010)
- La Rosa S, "Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors", Hum Pathol, 40, pp.30~40 (2009)
- Rindi G, "TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system", Virchows Arch, 449, pp.395~401 (2006)
- Volante M, "The grey zone between pure (neuro)endocrine and non-(neuro)endocrine tumours: a comment on concepts and classification of mixed exocrine-endocrine neoplasms", Virchows Arch, 449, pp.499~506 (2006)
- Tang LH, "High grade transformation of differentiated neuroendocrine neoplasms (NENs) of the enteropancreatic system: a unique entity distinct from de novo high grade neuroendocrine carcinoma (HGNECa) in pathogenesis and clinical behavior", Lab Invest, 88(Suppl 1), pp.137~ (2008)
- La Rosa S, "Lipid-rich variant of appendiceal well-differentiated endocrine tumor (carcinoid)", Am J Clin Pathol, 133, pp.809~814 (2010)
- Soga J, "Pathologic analysis of carcinoids: histologic reevaluation of 62 cases", Cancer, 28, pp.990~998 (1971)
- Adsay V, "Ki67 labeling index in neuroendocrine tumors of the gastrointestinal and pancreatobiliary tract: to count or not to count is not the question, but rather how to count", Am J Surg Pathol, 36, pp.1743~1746 (2012)
- Rindi G, "TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study", J Natl Cancer Inst, 104, pp.764~777 (2012)